Advanced search
Publication Cover
International Journal of Women's Health Volume 16, 2024 - Issue
Submit an article Journal homepage
47
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Value of Molecular Typing Combined with Integrated Positron Emission Tomography/Magnetic Resonance Imaging in Risk Stratification of Endometrial Cancer

Xuan Wang1 Department of Gynecology, Xuanwu Hospital Capital Medical University, Beijing, 100053, People’s Republic of ChinaView further author information
,
Yi-Fan Wang2 Department of Gynecology, Beijing Youan Hospital Capital Medical University, Beijing, 100069, People’s Republic of ChinaView further author information
&
Shi-Jun Wang1 Department of Gynecology, Xuanwu Hospital Capital Medical University, Beijing, 100053, People’s Republic of ChinaCorrespondence[email protected]
View further author information
Pages 831-842 | Received 10 Oct 2023, Accepted 15 Apr 2024, Published online: 16 May 2024

References

  • Siegel RL, Wagle NS, Cercek A, Smith RA, Jemal A. Colorectal cancer statistics, 2023. CA Cancer J Clin. 2023;73(3):233–254. doi:10.3322/caac.21772
  • Dai YB, Wang JL. Molecular typing of endometrial carcinoma and its clinical application. Chin Clin J Obstet Gynecol. 2022;23(02):113–115.
  • Talhouk A, McConechy MK, Leung S, et al. A clinically applicable molecular-based classification for endometrial cancers. Br J Cancer. 2015;113(2):299–310. doi:10.1038/bjc.2015.190
  • Abu-Rustum N, Yashar C, Arend R, et al. Uterine neoplasms, Version 1.2023, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2023;21(2):181–209.
  • Oaknin A, Bosse TJ, Creutzberg CL, et al. ESMO guidelines committee. Electronic address: [email protected]. Endometrial cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol. 2022;33(9):860–877. doi:10.1016/j.annonc.2022.05.009
  • Chinese anti-cancer association gynecological tumor professional committee. Guidelines for diagnosis and treatment of endometrial cancer (2021 edition). Chinese J Cancer. 2021;31(6):501–512.
  • Wang M, Gong J, Meng YG. Clinical application of positron emission tomography/magnetic resonance imaging in gynecological malignant tumor. Chin Clin J Obstet Gynecol. 2016;17(04):382–384.
  • Wang J, Yuan JJ, Wang YD. 2022 interpretation of the clinical practice guidelines for endometrial cancer of the European society of medical oncology. Chin J Prac Gynecol Obstet. 2022;38(08):827–829.
  • Rayner E, van Gool IC, Palles C, et al. A panoply of errors: polymerase proofreading domain mutations in cancer. Nat Rev Cancer. 2016;16(2):71–81. doi:10.1038/nrc.2015.12
  • Shinbrot E, Henninger EE, Weinhold N, et al. Exonuclease mutations in DNA polymerase epsilon reveal replication strand specific mutation patterns and human origins of replication. Genome Res. 2014;24(11):1740–1750. doi:10.1101/gr.174789.114
  • McCluggage WG, Singh N, Gilks CB. Key changes to the World Health Organization (WHO) classification of female genital tumours introduced in the 5th edition (2020). Histopathology. 2022;80(5):762–778. doi:10.1111/his.14609
  • Stelloo E, Nout RA, Osse EM, et al. Improved risk assessment by integrating molecular and clinicopathological factors in early-stage endometrial cancer-combined analysis of the PORTEC cohorts. Clin Cancer Res. 2016;22(16):4215–4224. doi:10.1158/1078-0432.CCR-15-2878
  • Cheng AS, Li J, Lin ZQ. Interpretation of the 2020 ESGO-ESTRO-ESP guidelines for the management of endometrial cancer patients. Chin J Prac Gynecol Obstet. 2021;37(03):336–341.
  • Concin N, Matias-Guiu X, Vergote I, et al. ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma. Radiother Oncol. 2021;154:327–353. doi:10.1016/j.radonc.2020.11.018
  • McAlpine JN, Chiu DS, Nout RA, et al. Evaluation of treatment effects in patients with endometrial cancer and POLE mutations: an individual patient data meta-analysis. Cancer. 2021;127(14):2409–2422. doi:10.1002/cncr.33516
  • Sun ZZ. Clinical Pathological Characteristics and Prognosis of POLE Mutant High-Grade Endometrial Carcinoma. Chinese Academy of Medical Sciences and Peking Union Medical College; 2020.
  • Zong LJ, Xiang Y, Huang WH. Research progress of molecular typing in the treatment of endometrial carcinoma with fertility preservation function. Obstet Gynecol. 2022;31(7):554–556.
  • Li WQ, Shen Y. Molecular typing and clinicopathological characteristics of endometrial carcinoma. Chin J Pathol. 2022;51(10):993–999. doi:10.3760/cma.j.cn112151-20220722-00639
  • Momeni-Boroujeni A, Dahoud W, Vanderbilt CM, et al. Clinicopathologic and genomic analysis of TP53-mutated endometrial carcinomas. Clin Cancer Res. 2021;27(9):2613–2623. doi:10.1158/1078-0432.CCR-20-4436
  • León-Castillo A, Gilvazquez E, Nout R, et al. Clinicopathological and molecular characterisation of ‘multiple-classifier’ endometrial carcinomas. J Pathol. 2020;250(3):312–322. doi:10.1002/path.5373
  • Ironi G, Mapelli P, Bergamini A, et al. Hybrid PET/MRI in staging endometrial cancer: diagnostic and predictive value in a prospective cohort. Clin Nucl Med. 2022;47(3):e221–e229. doi:10.1097/RLU.0000000000004064
  • Paquette M, Espinosa-Bentancourt E, Lavallée É, et al. 18F-4FMFES and 18F-FDG PET/CT in estrogen receptor-positive endometrial carcinomas: preliminary report. J Nucl Med. 2022;63(5):702–707. doi:10.2967/jnumed.121.262617
  • Ghooshkhanei H, Treglia G, Sabouri G, Davoodi R, Sadeghi R. Risk stratification and prognosis determination using (18)F-FDG PET imaging in endometrial cancer patients: a systematic review and meta-analysis. Gynecol Oncol. 2014;132(3):669–676. doi:10.1016/j.ygyno.2014.01.039

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.